Recently Added |View All
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.
While respiratory muscle dysfunction is well-documented, it’s often an underdiagnosed cause of dyspnea, and requires a multidisciplinary approach. Sources range from focal diaphragm dysfunction to systemic neuromuscular disease, often ...
Standardizing the Pulmonary Embolism care with Pulmonary Embolism Response Teams (PERT)
This activity is intended for medical professionals who have a clinical interest in the management of pulmonary embolisms as seen by the following medical specialists: Pulmonologists, Hospitalists, Intensivists, Primary Care Providers, ...
Lung Cancer Screening and SPN in the Patient with COPD
Patients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.
In this podcast recorded by the American Association of Bronchology and Interventional Pulmonology, Gerard J. Criner, MD discusses patient selection for Bronchoscopic Lung Volume Reduction.
Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.
Role of Chest Imaging in Bronchoscopic Lung Volume Reduction Using Endobronchial Valves
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and morbidity worldwide.
Humidified Nasal High-Flow Therapy May Be an Effective At-Home Treatment for COPD
A pilot study at Temple suggests that daily use of humidified nasal high-flow (NHF) therapy with an air-oxygen blend as a maintenance therapy could benefit patients discharged from hospital after an acute exacerbation of COPD.
Case Study: Elevated Hemidiaphragm
A 60-year-old man with multiple co-morbidities presented for evaluation of dyspnea.
New Treatment Pathways for Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN, also known as neonatal pulmonary hypertension and persistent fetal circulation syndrome), affects 2% of live births and is a major cause of neonatal mortality.
Gala Therapuetics RheSolve Study Treating Patients with Chronic Bronchitis
Gerard J. Criner, MD, FACP, FACCP, outlines the details of the Gala Therapeutics RheSolve Study for treating patients with chronic bronchitis.
Bronchoscopic Lung Volume Reduction Procedural Tips and Tricks
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. Despite optimal pharmacological treatment, many patients with chronic obstructive pulmonary disease remain very disabled.
Surgical Approaches to Lung Transplantation
Lung transplantation surgical techniques have been well standardized for the past three decades. In this educational activity attendees will learn of current standard surgical techniques for lung transplantation as practiced at Temple ...
PERT Transforms
Pulmonary Embolism Care
and Practice
Pulmonary embolism (PE) is the third most common cardiovascular cause of inpatient hospital death in the United States, and the prevalence of PE risk factors—including surgery, obesity, a sedentary or immobile lifestyle, and advanced age—is ...
Asthma is a global health problem that affects approximately 300 million people in all age and ethnic groups. There is an estimated 250,000 deaths each year related to or resulting from Asthma. Treatment guidelines can be difficult to ...
Metered dose Nitrogen Cryospray for Treatment of Chronic Bronchitis in Patients with COPD (SPRAY-CB)
Gerard Criner, MD, FACP, FACCP, outlines the details of the SPRAY-BC clinical trial for the treatment of chronic bronchitis in patients with COPD.